Abstract
Introduction
The National Institutes of Health (NIH) is the major source federal funds for biomedical research in the United States. The NIH budget is approved by Congress each year, and in fiscal year 2014, the total NIH budget was 30.3 billion dollars (REF) . The NIH is divided into 25 institutes, each with its own focus and mission. For example, National Cancer Institue (NCI) focuses on malignant diseases; the National Institute for Allergy and Immune Disease focuses on the immune system and transmissible diseasei; and the National Institute for General Medical Sciences focuses on basic research without a specific disease focus. Each institute negotiates with the NIH director (currently Francis Collins, MD, PhD) for its yearly budget, with budget institutes ranging from millions to several billion dollars.
The NIH provides funds through competetive grants written by internal and external investigators, and the funds associated with these grants can be divided into 'direct' and 'indirect' costs. Direct costs are funds that are given to an investigator (or group of investigators) to conduct their proposed research. These funds buy supplies for the experiments and pay the salaries of people to do the work.
By contrast, indirect costs are funds that are paid to institutions associated with investigators, and are used to "keep the lights on": they pay for infrastructure costs. However, the "indirect cost recovery" (ICR) rate of each institution, the fraction of each award the institute receives, is congressionally mandated, and there is a wide range in ICR rates. Some of the highest ICR rates are close to 100%, meaning that for every dollar an investigator receives, the institutions receive an equal amount.
NIH funding is an investment strategy: the institutes invest money in specific research areas, hoping for future returns in the form of publications, patents and skilled trainees. As with any investment strategy, a periodic review can help rebalance the portfolio in order to maximize returns. Analysis of NIH funding data has been performed internally by the NIH, or by contracted third-parties. Several of these analyses have highlighted funding trends and suggested metrics to gauge the 'return' on the NIH 'investment'. For example, "productivity" can be examined as a function of the number of publications produced by grants per dollar of "direct costs".
Methods
We downloaded NIH funding data from the NIH EXPORTER website in comma-separated value (CSV) format and parsed these data into R data files that each contain specific information:
• projects has information about projects in each fiscal year, keyed by project.num • org_info has information about project organizations • project_orgs links applications to organizations • project_pis links PI information to a project • publinks table links PubMed IDs to project.num • publications links project IDs to PubMed IDs • patents links patent IDs to project IDs See the documentation in the R package for more information about each table.
The package also has several precomputed variables and tables that enable quick and easy exploratory analysis:
• nih.institutes: Two-letter format for 27 NIH institutes • project_io: This table contains pre-computed values for overall project cost (project.cost), as well as the number of publications (n.pubs) and patents (n.patents) associated with each project.
NIH EXPORTER provides access to the total costs of each grant in each fiscal year, comprising both direct and indirect costs.
We developed several analyses using the dplyr, ggplot2 and knitr packages in the RStudio environment.
Results and Discussion

Project costs
Let's look at the costs of grants over time for a few institutes: 
Funding distributions
By Institution
Let's look where the money is going. This example illustrates linking of the project, org_info and project_orgs tables. We can also identify movers-and-shakers by institution.
By PI
One can also examine how dollars are accrued by specific PIs. It is not possible to assign dollars directly to a PI, because some grants have multiple investigators. Rather, these are total costs that a given PI has been associated with over all grants in NIH EXPORTER. Here we identify PIs with the largest dollar amounts accrued for R01 grants. 
Productivity
In order to measure the "return" on the money the NIH invests in the research enterprise, we can measure scholarly output (i.e., publications) per dollar invested.
Here we identify th highest performing grants outside of the R01 category. Much has been made of the wasteful spending outside of investigator-initiated research. Here we identify the cost of publications for grants other than R01's that cost more than 1 million dollars. When Jeremy Berg was head of the Institute of General Medical Sciences (NIGMS) from 2003-2011, he routinely provided analysis of funding trends at NIGMS in his "Feedback Loop" blog. One of these measured the productivity per grant dollar by measuring its "scholarly output" (i.e., publications) as a function of direct costs. In this plot there is an increase in productivity per dollar, until an inflection point at $700K, after which the number of publications drops, suggesting a negative influence of grant money on scholarly output. This was interesting and covered here.
Here we flesh out this analysis and look at how all institutes perform by this measure (Berg, and now Lorsch, only analyzed GM). One caveat is that we only have access to total.cost in NIH EXPORTER, so the numbers include indirect costs. But, this is real cost to the tax-payer.
First, we need to calculate the lifetime costs of all R01 grants. -c(175000, 200000, 225000, 250000, 300000, 375000, 400000, # 450000, 500000, 600000, 700000, 800000, 900000, 1000000) min.lifetime.cost <round(min(grant_costs$total.cost), -4) # round to 10,000s max.lifetime.cost <round(max(grant_costs$total.cost), -5) # step is average size of an award step <-1e6 breaks <seq(min.lifetime.cost, max.lifetime.cost, step) breaks #> [1] 0.0e+00 1.0e+06 2.0e+06 3.0e+06 4.0e+06 5.0e+06 6.0e+06 7.0e+06 #> [9] 8.0e+06 9.0e+06 1.0e+07 1.1e+07 1.2e+07 1.3e+07 1.4e+07 2e+07 3.3e+07 3.4e+07 3.5e+07 3.6e+07 3.7e+07 3.8e+07 3.9e+07 #> [41] 4.0e+07 4.1e+07 4.2e+07 4.3e+07 4.4e+07 4.5e+07 4.6e+07 4.7e+07 #> [49] 4.8e+07 4.9e+07 5.0e+07 5.1e+07 5.2e+07 5.3e+07 5.4e+07 5.5e+07 #> [57] 5.6e+07 5.7e+07 5.8e+07 5.9e+07 6.0e+07 6.1e+07 6.2e+07 6.3e+07 #> [65] 6.4e+07 6.5e+07 6.6e+07 6.7e+07 6.8e+07 6.9e+07 7.0e+07 7.1e+07 #> [73] 7.2e+07 7.3e+07 7.4e+07 7.5e+07 7.6e+07 
Comparison of grant programs
The NIH provides funds through differet grant programs:
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Total costs (minimum, in millions) • program: activities begin with P (e.g. P01)
Number of publications
• contract: actvities begin with U (e.g. U54)
We can examine the total costs spent on specific grants and specific institutes over time. c(1e4,1e7) , labels = trans_format("log10", math_format(10^.x))) + facet_wrap ( 
AI
Duration
The nihexporter exposes project.start and project.end, which we can use to examine the duration of projects. For example, we can identify the longest running R01 grants. long.grants %>% head(10) %>% knitr::kable(digits = 2, caption = Longest running R01 grants (all-time) , col.names=c( Project ID , Duration (years) )) 
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